Public AtlasExperiments

Public Atlas · Experiment record

AST mVOC Ciprofloxacin July 2026

A citable scientific record connecting experimental context to runs, plates, wells, sensors, raw measurements, processing, and derived evidence.

Atlas accession
AST-CIP-2026-07
Record state
Screening
Release
Atlas v0
Last updated
2026-07-29
Download CSV View JSON Open signals
Citation text

RAPID-iNose Sensor Atlas. AST mVOC Ciprofloxacin July 2026. AST-CIP-2026-07. Atlas v0. https://rapid-inose-atlas.duckdns.org/experiments/6/

Raw signal 1,361,784 audited rows Immutable source values retained for 60 samples. Row total comes from the locked normalization audit.
Source provenance 5 artifacts Registered filenames and SHA-256 checksums; private paths remain hidden.
QC 360 records QC records describe trace eligibility and do not validate a diagnosis.
Normalization ast_signed_percent_15min_v1 Derived values are reproducible and never replace raw signal rows.
Derived evidence 34,560 values Features and normalized measurements remain linked to source records.

Scientific scope

Experiment overview

Antibiotic response
Runs 5
Plates 5
Samples 60
Organisms 6
Replicate groups 0

Objective

A formal experimental objective has not yet been curated. See the description and protocol context below.

Description

Curated 12-well antibiotic concentration series with raw per-sensor resistance, explicit control subtypes, visual growth calls, and source-document provenance.

Experiment period
July 22, 2026 to July 23, 2026
Medium
TSB
Protocol summary
Not yet curated
Published normalization
Imported normalized value
Sensor manufacturing batch
Not publicly disclosed

Experiment → run → plate → well

Record hierarchy

Each identifier opens a permanent, publication-scoped scientific record.

Plate records

PlateOrganismAntibioticPhenotypeEvidenceWellsControls
RINA-AST-000016Escherichia coli ATCC 25922CiprofloxacinSusceptibleScreening122
RINA-AST-000017Escherichia coli ATCC BAA-196CiprofloxacinResistantScreening122
RINA-AST-000019Pseudomonas aeruginosa ATCC 27853CiprofloxacinSusceptibleScreening122
RINA-AST-000020Pseudomonas aeruginosa ATCC BAA-2108CiprofloxacinResistantScreening122
RINA-AST-000018Staphylococcus aureus 252 (source label)CiprofloxacinUnknownScreening122

Data contract

Measurement lineage

Raw signal → source provenance → QC → normalization → derived evidence.

1
Raw signal1,361,784 audited rowsImmutable source values retained for 60 samples. Row total comes from the locked normalization audit.
2
Source provenance5 artifactsRegistered filenames and SHA-256 checksums; private paths remain hidden.
3
QC360 recordsQC records describe trace eligibility and do not validate a diagnosis.
4
Normalizationast_signed_percent_15min_v1Derived values are reproducible and never replace raw signal rows.
5
Derived evidence34,560 valuesFeatures and normalized measurements remain linked to source records.
Raw signal rows
1361784 audited rows
Samples with raw signal
60 of 60
QC records
360
Derived features
0
Normalized measurements
34560

Provenance

Registered source artifacts

Checksums identify source content without exposing server paths.

AccessionTypeFilenameSHA-256Size
RINA-SRC-000017Curated exportast_mvoc_curated_manifest.csv88b3f06323012113d8864fd0733afe55ed564062eef6417dcb927c96998cb1a844318 bytes
RINA-SRC-000016ManifestWaqas_Antibiotic_MIC_Data.xlsx58da6a46203986584b9dab7b4f5fcec917d92d2f67ee64df2e6e84fac245106215922 bytes
RINA-SRC-000015PresentationCiprofloxacin_MIC_072326.pptxb01e86a15f6f797afb1d8bbb825516fc861a02be4584b4b848611957e145cda124746814 bytes
RINA-SRC-000014PresentationInitial_AST_mVOC_objectives_and_tasks_12JUL26_WCJD.pptx7feae8b10a06f36b567afe566130c65ec4baece660171ab23d2342cd00c1e4e425400108 bytes
RINA-SRC-000013Raw archive2026-07-23.zipb6d7c98090fe8d384bdcc5ddcf42a30989baec4edeb60d525bdc555b494e12818113592 bytes